Collins Cooper C. 4
4 · TherapeuticsMD, Inc. · Filed Feb 20, 2025
Insider Transaction Report
Form 4
Collins Cooper C.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-18+8,500→ 60,516 total - Exercise/Conversion
Restricted Stock Units
2025-02-18−8,500→ 0 totalExercise: $0.00→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 8,500 shares of common stock of the issuer in settlement of RSUs, which vested on July 17, 2024.